Accolade, Inc. (ACCD)
After hours:
- Benzinga
Analyst Initiates Coverage On Accolade, Says 'Differentiated In Growing Market'
Raymond James initiated coverage on Accolade Inc (NASDAQ: ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected point solutions, which are generally under-used, lack a common IT platform, and have further convoluted an already-complex ecosystem, writes the analyst. Related: Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop. Accolade integrates an employer’s health benefits into a unified platf
- Simply Wall St.
With stock up 14%, Insiders of Accolade, Inc. (NASDAQ:ACCD) must be wishing they had bought more last year
Accolade, Inc. ( NASDAQ:ACCD ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...
- PR Newswire
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care
Blue Shield of California today unveiled its Virtual Blue health benefits plan offering members easy-to-access, comprehensive care through a team of "virtual-first" primary, behavioral, and specialist healthcare professionals.
